Medicen Paris Region Cluster

Home > France means business > Why choose France? > International Clusters > Medicen Paris Region Cluster

Medicen Paris Region Cluster

The “Medicen Paris Region” cluster brings together nearly a thousand enterprises, as well as hospitals and research centers such as the Pasteur Institute, the Evry Génopole and the Atomic Energy Center (CEA) biotechnologies labs. It specializes in infectious, central nervous system and eye diseases, as well as oncology (the Gustave Roussy Institute). This cluster is at the technological cutting edge of medical imaging, and molecular and cell medicine.

Region / Ville

Ile-de-France / Paris

Sector of activity

Cancer – Diseases of the nervous system – Infectious diseases (antibiotics,…)
Medical imaging – molecular and cellular therapies (genomic therapy, stem cells, applications for genetic diseases, etc.) – Pharmaceutical drugs

Budget

The budget for this structure could total approximately 1 million euros per year. Total financing of players’ R&D activities is estimated at approximately 260 million euros over 3 years.

Objectives

Position itself as the leading European industrial cluster in the field of therapeutic innovation (neurosciences, oncology, infectious diseases) and technology (molecular and cellular therapies, medical imaging, pharmaceutical science and technology)
Consolidate the economic attractiveness of the cluster in the field of healthcare to encourage investment and employment
Increase the number of private sector jobs in life sciences and technologies by 50%
Double the numbers of personnel in biotechnology companies
Develop clinical research activities through increased cooperation with the French pharmaceutical industry and the creation of top level international technology platforms
Enable the pharmaceutical biotechnologies sector to achieve an international dimension and performance level, in order to ensure that the French pharmaceutical industry maintains its competitiveness.

Advantages offered by the cluster

Situated in a prime region: the Ile-de-France is the leading region in Europe and the 5th leading region worldwide in terms of research and development capacity (126 000 people).
90% of French companies specialized in clinical trials (conduite d’essais cliniques – CRO) are located in the Ile-de-France region and are supported by the biggest hospital network in the world: the French public hospitals network (Assistance Publique-Hôpitaux de Paris AP-HP).
Several prestigious institutes and research laboratories are located in the region (Pasteur Institute, Curie Institute, INSERM…), the majority of major industrial groups in the pharmaceutical industry have located their headquarters or sales divisions in the region.

Main partners

Companies

Market leaders in their fields: Novo Nordisk, Novartis, Philips Medical Systems, Sanofi-Aventis, Servier, Siemens, Sun Microsystems, Zeiss, Cap Gemini, Danone, General Electric Healthcare, GlaxoSmithKline, Harrison Clinical Research, Chemunex, Denoyelle, Hamamatsu, Medasys-Hitachi, Ipsen, etc.
A highly dense network of small and mid-sized companies and industries: Anaconda Pharma, ABS Science, Agilent, Ariana Pharmaceuticals, Affymetrix, Bioalliance Pharma, Biospace, Bioprotein Technologies, Cell Tissues Progress, Cytomics, Diverchem, Echosens, Eucodys, Geneware, Genescore, Genzyme/Myosix, Integraren, Helios Biosciences, MAT, etc.

Research

CEA, INSERM, CNRS, Pasteur Institute, Curie Institute, Gustave Roussy Institute Cancer Cluster, French public hospital network (Assistance Publique Hôpitaux de Paris), INRA, INRIA, Maison-Alfort Veterinary School

Training

9 universities offering complete biology and connected sciences courses, 2 higher schools, top level engineering schools.
Paris V, VI, XI, XII, XIII Universities, Evry University, Versailles University, Cergy University, Cachan and Ulm Higher Schools, INAPG, Ecole Central de Paris school, Ecole des Mines de Paris school, IBPI, ESPCI